Relief/NN
of/IN
cyclin/NN
A/NN
gene/NN
transcriptional/JJ
inhibition/NN
during/IN
activation/NN
of/IN
human/JJ
primary/JJ
T/NN
lymphocytes/NNS
via/IN
CD2/NN
and/CC
CD28/NN
adhesion/NN
molecules/NNS
./.

Cyclin/NN
A/NN
transcription/NN
is/VBZ
cell/NN
cycle/NN
regulated/JJ
and/CC
induced/VBN
by/IN
cell/NN
proliferative/JJ
signals/NNS
./.
=====
To/TO
understand/VB
the/DT
mechanisms/NNS
underlined/VBN
in/IN
this/DT
regulation/NN
in/IN
normal/JJ
human/JJ
cells/NNS
,/,
we/PRP
have/VBP
analysed/VBN
in/FW
vivo/FW
protein-DNA/JJ
interactions/NNS
at/IN
the/DT
Cyclin/NN
A/NN
locus/NN
in/IN
primary/JJ
T/NN
lymphocytes/NNS
./.
=====
Stimulation/NN
of/IN
purified/VBN
T/NN
lymphocytes/NNS
by/IN
a/DT
combination/NN
of/IN
monoclonal/JJ
antibodies/NNS
directed/VBN
at/IN
CD2/NN
and/CC
CD28/NN
adhesion/NN
molecules/NNS
gives/VBZ
rise/NN
to/TO
a/DT
long/JJ
lasting/JJ
proliferation/NN
in/IN
the/DT
absence/NN
of/IN
accessory/NN
cells/NNS
./.
=====
Cyclin/NN
A/NN
was/VBD
observed/VBN
after/IN
4/CD
days/NNS
of/IN
costimulation/NN
with/IN
anti/JJ
CD2/NN
+/CC
CD28/NN
whereas/IN
stimulation/NN
by/IN
anti/JJ
CD2/NN
or/CC
anti/JJ
CD28/NN
alone/RB
was/VBD
not/RB
effective/JJ
./.
=====
In/FW
vivo/FW
genomic/JJ
DMS/NN
footprinting/NN
revealed/VBD
upstream/RB
of/IN
the/DT
major/JJ
transcription/NN
initiation/NN
sites/NNS
,/,
the/DT
presence/NN
of/IN
at/IN
least/JJS
three/CD
protein/NN
binding/NN
sites/NNS
,/,
two/CD
of/IN
which/WDT
were/VBD
constitutively/RB
occupied/VBN
./.
=====
They/PRP
bind/VBP
in/FW
vitro/FW
respectively/RB
ATF-1/NN
and/CC
NF-Y/NN
proteins/NNS
./.
=====
The/DT
third/JJ
site/NN
was/VBD
occupied/VBN
in/IN
quiescent/JJ
cells/NNS
or/CC
in/IN
cells/NNS
stimulated/VBN
by/IN
anti/JJ
CD2/NN
or/CC
anti/JJ
CD28/NN
alone/RB
./.
=====
The/DT
mitogenic/JJ
combination/NN
of/IN
anti/JJ
CD2/NN
+/CC
anti/JJ
CD28/NN
released/VBD
the/DT
footprint/NN
as/IN
cells/NNS
were/VBD
committed/VBN
to/TO
proliferation/NN
./.
=====
Consistent/JJ
with/IN
theses/DT
results/NNS
,/,
nuclear/JJ
extracts/NNS
prepared/VBN
from/IN
quiescent/JJ
cells/NNS
formed/VBD
a/DT
specific/JJ
complex/NN
with/IN
this/DT
element/NN
,/,
whereas/IN
extracts/NNS
prepared/VBN
from/IN
cells/NNS
treated/VBN
with/IN
anti/JJ
CD2/NN
+/CC
anti/JJ
CD28/NN
failed/VBD
to/TO
do/VB
so/RB
after/IN
cells/NNS
entered/VBD
a/DT
proliferative/JJ
state/NN
./.